BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2048199)

  • 1. Acceptance of H-Y-disparate corneal grafts despite concomitant immunization of the recipient.
    He YG; Ross J; Callanan D; Niederkorn JY
    Transplantation; 1991 Jun; 51(6):1258-62. PubMed ID: 2048199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differential effects of donor versus host Langerhans cells in the rejection of MHC-matched corneal allografts.
    Ross J; He YG; Pidherney M; Mellon J; Niederkorn JY
    Transplantation; 1991 Nov; 52(5):857-61. PubMed ID: 1949172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of gender incompatibility in donors and recipients and the role of minor histocompatibility antigens in corneal transplantation].
    Hasková Z; Filipec M; Holán V
    Cesk Slov Oftalmol; 1997 May; 53(2):128-35. PubMed ID: 9296861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of tissue culture on corneal immunogenicity.
    Gabric N; Dekaris I; Suman L; Karaman Z; Mravicic I
    Exp Eye Res; 1999 Mar; 68(3):277-82. PubMed ID: 10079135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice.
    Sano Y; Ksander BR; Streilein JW
    Transpl Immunol; 1996 Mar; 4(1):53-6. PubMed ID: 8762011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of oral immunization on corneal allograft survival.
    He YG; Mellon J; Niederkorn JY
    Transplantation; 1996 Mar; 61(6):920-6. PubMed ID: 8623161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that the fate of class II-disparate corneal grafts is determined by the timing of class II expression.
    Ross J; Callanan D; Kunz H; Niederkorn J
    Transplantation; 1991 Feb; 51(2):532-6. PubMed ID: 1994550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthotopic corneal transplantation in mice--evidence that the immunogenetic rules of rejection do not apply.
    Sonoda Y; Streilein JW
    Transplantation; 1992 Oct; 54(4):694-704. PubMed ID: 1412761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mismatches for major histocompatibility complex and minor antigens on corneal graft rejection.
    Nicholls SM; Bradley BB; Easty DL
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2729-34. PubMed ID: 1894472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
    Sonoda Y; Sano Y; Ksander B; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavior of male-specific minor histocompatibility antigen in skin and limb transplantation.
    Muramatsu K; Kurokawa Y; Ihara K; Sakamoto S; You-Xin S; Kawai S
    J Surg Res; 2003 Nov; 115(1):106-12. PubMed ID: 14572780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class I disparate corneal grafts enjoy afferent but not efferent blockade of the immune response.
    Ross J; He YG; Niederkorn JY
    Curr Eye Res; 1991 Sep; 10(9):889-92. PubMed ID: 1790719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation immunity and tolerance in the eye: rejection and acceptance of orthotopic corneal allografts in mice.
    Holán V; Hasková Z; Filipec M
    Transplantation; 1996 Oct; 62(8):1050-4. PubMed ID: 8900299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical role of lymph nodes in corneal alloimmunization and graft rejection.
    Yamagami S; Dana MR
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1293-8. PubMed ID: 11328742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of topical interleukin-1 receptor antagonist (IL-1ra) on corneal allograft survival in presensitized hosts.
    Dekaris IJ; Yamada JJ; Streilein WJ; Dana RM
    Curr Eye Res; 1999 Nov; 19(5):456-9. PubMed ID: 10520223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunogenic privilege of corneal allografts.
    Niederkorn JY; Peeler JS; Ross J; Callanan D
    Reg Immunol; 1989; 2(2):117-24. PubMed ID: 2701814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.